BMJ  2005;330 (4 June), doi:10.1136/bmj.330.7503.0-d

Aspirin to prevent cardiovascular disease in elderly people: the jury's still out

We don't know how justified routine use of low dose aspirin is for primary prevention of cardiovascular disease in people aged 70 and more. Nelson and colleagues (p 1306) undertook epidemiological modelling in a hypothetical population of 20 000 men and women with the reference population of Victoria, Australia, and showed that aspirin prevented 710 myocardial infarctions and 54 ischaemic strokes. However, it also provoked the onset of gastrointestinal and intracranial bleeding in 1071 and 130 patients, respectively. Wide confidence intervals leave room for the overall effect to be either beneficial or adverse.

Credit: SUSA/FOTEX/REX


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Citizen jury should consider aspirin prophylaxis
Rachel T Iredale
BMJ 2005 331: 160. [Extract] [Full Text]

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≥70
Mark R Nelson, Danny Liew, Melanie Bertram, and Theo Vos
BMJ 2005 330: 1306. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Aspirin to prevent cardiovascular disease in elderly people: Benefits outweigh risks for most
Thomas E. Bryant
bmj.com, 18 Jun 2005 [Full text]



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview